Blog

Allergan CEO, fresh off one deal, sets sights on others

Allergan CEO Brent Saunders said on Monday the company will use the $36 billion it nets from the sale of its generics business to Teva for more deals, including large, “transformational” merger opportunities. Saunders, who led the $66 billion combination of Actavis and Allergan that closed only a few months ago, told investors that it would use the proceeds from its $40.5 billion sale to Teva to increase the size

Arab ministers to meet after Jerusalem clashes

Arab League foreign ministers will meet in Cairo early next month to discuss clashes involving Israeli police at the Al-Aqsa mosque compound in Jerusalem, a senior Palestinian official said Monday. Sunday’s incident saw Israeli police enter the mosque, one of Islam’s holiest sites, as they clashed with Palestinians angered by Jews’ access to the compound on an annual day of Jewish mourning. Chief Palestinian negotiator Saeb Erakat told reporters that

UK says investigating two suspected MERS cases in northern England

LONDON (Reuters) – Two suspected cases of the Middle Eastern Respiratory Virus Syndrome (MERS) have forced a hospital in northern England to shut its emergency wing, health officials said on Monday. Two patients at Manchester Royal Infirmary had been placed in isolation for ongoing treatment, but there was no significant risk to others at the hospital or the general public, Central Manchester University Hospitals Trust said in a statement on